2022 Hematology and Oncology Best Practices Conference

Join us for the most comprehensive board review conference, designed specifically for physicians preparing to take the Hematology and Oncology certification exams or those seeking a comprehensive update of hematology and medical oncology standards of care.

Program Dates: August 11-18, 2022

Target Audience

This conference is ideal for physicians preparing to take the Hematology and Oncology certification exams, as well as individuals desiring a comprehensive review of hematology and medical oncology standards of care.

Learning Objectives

At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

Hematology

• Understand established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
• Understand established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
• Understand blood and marrow morphology and hematopathology
• Understand red cell disorders

Hematologic Malignancies

• Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
• Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
• Identify strategies for taking the board examinations

Oncology

• Understand the epidemiology of malignant diseases and management of the medical complications of malignancy
• Comprehend the principles of management of gynecologic and other genito-urinary malignancies
• Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract
• Recognize principles of new developments in biologic therapy of cancer
• Contend with complexity of HIV-related malignancies

Course Overview

The Hematology and Oncology Best Practices conference is divided into three main sessions: Hematology, Hematologic Malignancies, and Medical Oncology.

Hematology Sessions

• Day 1: Hemoglobinopathies, White Cell Disorders, Bone Marrow Failure, and Sickle Cell Disease Overview
• Day 2: Clotting and Bleeding Disorders
• Day 3: TTP, HUS, DIC, HIT, ABO Incompatibility, Hematopoietic Transplantation, and Hematologic Complications of Pregnancy

Hematologic Malignancies Sessions

• Day 4: Lymphomas, CLL, ALL, CML, Plasma Cell Disorders, and MDS
• Day 5: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms, and Pharmacology

Medical Oncology Sessions

• Day 6: Breast Cancer, Lung Cancer, and Neuro-Oncology
• Day 7: Renal Cell, Prostate, Bladder, Testicular, Ovarian, and Endometrial Tumors
• Day 8: GI Oncology, Mesothelioma, and Sarcomas